Answers are grounded in this paper and cite their sources.
Statins are first line of treatment for patients diagnosed with dyslipidemia for lowering LDL cholesterol.Statins cause modest increases in HDL-C probably mediated by reductions in CETP activity.It is established to contribute to cardiovascular benefits.High HDL-C is associated with cardiovascular benefits but no upper limit has yet been established.Studies have shown that paradoxically extremely high HDL cholesterol levels are associated with an increased risk of atherosclerosis and cardiovascular events.Here we present a case of high HDL in a patient who was on statin and was reported to have suffered from episodes of cardiovascular events as well as cerebrovascular accident .
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (2023) studied this question.